NCT00037661已完成3 期
Double-Masked, Randomized, Placebo-Controlled Study of Efficacy Parameter Following Administration of INS365 Ophthalmic Solution or Placebo in a Controlled Adverse Environment (CAE) Chamber in Subjects With Non-Sjogren's Associated Dry Eye
适应症
相关药物
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 222
研究概览
简要总结
Comparative efficacy trial of INS365 Ophthalmic Solution and placebo in patients with dry eye.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Double
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •have Non-Sjogren's associated dry eye disease with symptoms lasting greater than 6 months
- •had intermittent or regular artificial tear use within past 3 months
排除标准
- •had LASIK surgery
- •had punctal occlusion or cauterization within last 3 months
研究者
相似试验
已完成
3 期
Study of INS365 Ophthalmic Solution in Subjects With Dry Eye DiseaseDry Eye DiseaseNCT00404131Merck Sharp & Dohme LLC500
已完成
3 期
Study of INS365 Ophthalmic Solution in Subjects With Dry Eye DiseaseDry Eye DiseaseNCT00403715Merck Sharp & Dohme LLC500
已完成
2 期
Safety and Efficacy of TOP1630 for Dry Eye SyndromeDry Eye SyndromeNCT03088605ORA, Inc.69
已完成
2 期
A Study of INS365 Ophthalmic Solution in Patients With Moderate to Severe Dry Eye DiseaseDry Eye DiseaseNCT00679718Merck Sharp & Dohme LLC150
已完成
2 期
Study of TOP1630 for Dry Eye SyndromeDry Eye SyndromeNCT03833388Topivert Pharma Ltd202